Pulmonary Arterial Hypertension PAH Clinical Trials in Hangzhou, Zhejiang
2 recruitingHangzhou, Zhejiang, China
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.
Pulmonary Arterial Hypertension PAH
ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.120 enrolled32 locationsNCT07593027
Recruiting
Not Applicable
Comparison of Sequential to Initial Combination Therapy in PAH
Pulmonary Arterial Hypertension PAH
Second Affiliated Hospital, School of Medicine, Zhejiang University376 enrolled1 locationNCT06968962